Octin Health Wins Medical Alley Innovation Showcase
The Eagan-hosted pitch event on Thursday named Octin Health the winner among five health and life science startups.
Updated on Nov. 7, 2026 in Healthcare
Live Poll
Do you trust new medical startups to improve patient care?
Octin Health, founded by Mayo Clinic-trained surgeon Meghana Helder, won the Medical Alley Innovation Showcase held Thursday at CliftonLarsonAllen in Eagan. Five startups each pitched to investors and entrepreneurs for eight minutes.
Why it matters
Octin's Elika device is designed to maintain blood flow during aortic arch surgery and potentially eliminate the need for deep hypothermic circulatory arrest. The win places the company's pitch in front of regional investors as it prepares its next funding round.
Octin has raised $4.7 million in seed funding and plans an $8-$10 million Series A round. The company's Elika device targets aortic arch surgery, where the operative mortality rate is cited at 9%, though the source does not detail how the device compares in outcomes.
The players
Octin Health
A Minnesota medical device startup developing the Elika system for aortic arch surgery, founded by surgeon Meghana Helder.
Meghana Helder
A Mayo Clinic-trained surgeon who founded Octin Health to address blood flow challenges during aortic arch procedures.
Medical Alley
A Minnesota health technology industry association that hosts startup pitch events connecting companies with investors.
The details
Octin's Elika device pairs with a bypass machine, and integrated balloons block the entry to give surgeons a clear field, enabling normal body temperature and blood flow during repair. Octin won the Minnesota Cup in September 2026 before taking the Eagan showcase.
Timeline
September 2026: Octin wins the Minnesota Cup state startup competition.
August 2026: Elika has its first clinical use.
Thursday, November 5, 2026: Medical Alley Innovation Showcase held in Eagan.
February 2027: Octin plans to launch its Series A round.
Spring 2027: Octin travels to Sydney, Australia for an international pitch competition.
Roadmap
Medical Alley has long served as a hub for Minnesota medical device development, and events like this one channel early-stage devices toward investment. Octin's Elika device addresses a surgical problem that has historically required deep hypothermic circulatory arrest, a technique the company hopes to make unnecessary.
If cleared, Elika could change how aortic arch surgery is performed by keeping blood flowing at normal body temperature during repair. Patients undergoing such procedures would not be affected until the device receives FDA clearance and reaches hospitals.
The takeaway
Early-stage medical devices often gain their first visibility through regional pitch events, and funding milestones like Octin's Series A will determine whether promising surgical technologies reach patients. Readers following the sector can track FDA submissions as the clearest signal of progress.
What happens next
Octin Health plans to submit Elika to the FDA for clearance early next year and to launch its Series A round in February 2027.
Further reading
Explore more Healthcare coverage tied to this Minnesota startup news.
Source note: This article includes information reported by Twin Cities Business.
Live Poll
Do you trust new medical startups to improve patient care?
